Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

For some bladder cancer patients, simple test could reduce over-treatment

For some bladder cancer patients, simple test could reduce over-treatment

Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

Enzalutamide shows efficacy in preventing aggressive prostate cancer becoming metastatic, deadly

Enzalutamide shows efficacy in preventing aggressive prostate cancer becoming metastatic, deadly

Early treatment of advanced prostate cancer with radioligand therapy prolongs life

Early treatment of advanced prostate cancer with radioligand therapy prolongs life

When one drug fails, a new door opens for cancer treatment

When one drug fails, a new door opens for cancer treatment

Fluciclovine PET/CT locates recurrent prostate cancer and advises management

Fluciclovine PET/CT locates recurrent prostate cancer and advises management

Improved PSMA-targeting agent more effective for prostate cancer diagnosis/therapy in mice

Improved PSMA-targeting agent more effective for prostate cancer diagnosis/therapy in mice

Lethal prostate cancer treatment may benefit from combination immunotherapy

Lethal prostate cancer treatment may benefit from combination immunotherapy

Research team discovers drug compound that stops cancer cells from spreading

Research team discovers drug compound that stops cancer cells from spreading

More from ecancer